The University Hospital of Tübingen is participating in a Europe-wide research project on immune imaging. In cooperation with the Werner Siemens Imaging Center, new immune cell tracers will be developed in Tübingen and subsequently tested in a clinical study in the Department of Nuclear Medicine and Clinical Molecular Imaging. The project is scheduled to run for five years and will receive 30 million euros in funding from the Innovative Medicines Initiative Joint Undertaking (IMI-JU). The Tübingen researchers have more than 1 million euros at their disposal. The research project complements the projects of the recently approved cluster of excellence "Image-Guided and Functionally Instructed Tumor Therapies" (iFIT).